Analysen von Richard Vosser
| 19.05.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 19.05.21 | Sanofi overweight | JP Morgan Chase & Co. | |
| 19.05.21 | Bayer overweight | JP Morgan Chase & Co. | |
| 13.05.21 | Merck overweight | JP Morgan Chase & Co. | |
| 12.05.21 | Merck overweight | JP Morgan Chase & Co. | |
| 06.05.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 05.05.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 05.05.21 | Sanofi overweight | JP Morgan Chase & Co. | |
|
Werbung
|
|||
| 05.05.21 | Merck overweight | JP Morgan Chase & Co. | |
| 04.05.21 | Merck overweight | JP Morgan Chase & Co. | |
| 28.04.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 28.04.21 | Sanofi overweight | JP Morgan Chase & Co. | |
| 28.04.21 | Merck overweight | JP Morgan Chase & Co. | |
| 26.04.21 | Sanofi overweight | JP Morgan Chase & Co. | |
| 22.04.21 | Sartorius vz. overweight | JP Morgan Chase & Co. | |
| 21.04.21 | Sartorius vz. overweight | JP Morgan Chase & Co. | |
| 14.04.21 | Sanofi overweight | JP Morgan Chase & Co. | |
| 13.04.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 09.04.21 | Sanofi overweight | JP Morgan Chase & Co. | |
| 08.04.21 | Sanofi overweight | JP Morgan Chase & Co. | |
| 07.04.21 | Sartorius vz. overweight | JP Morgan Chase & Co. | |
| 23.03.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 22.03.21 | Sartorius vz. overweight | JP Morgan Chase & Co. | |
| 19.03.21 | Nike overweight | JP Morgan Chase & Co. | |
| 17.03.21 | Sanofi overweight | JP Morgan Chase & Co. | |
| 16.03.21 | Merck overweight | JP Morgan Chase & Co. | |
| 15.03.21 | Sanofi overweight | JP Morgan Chase & Co. | |
| 05.03.21 | Merck overweight | JP Morgan Chase & Co. | |
| 04.03.21 | Merck overweight | JP Morgan Chase & Co. | |
| 12.02.21 | Sanofi overweight | JP Morgan Chase & Co. | |
| 09.02.21 | Merck overweight | JP Morgan Chase & Co. | |
| 08.02.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 08.02.21 | Sanofi overweight | JP Morgan Chase & Co. | |
| 05.02.21 | Sanofi overweight | JP Morgan Chase & Co. | |
| 03.02.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 03.02.21 | Merck overweight | JP Morgan Chase & Co. | |
| 29.01.21 | Sartorius Stedim Biotech overweight | JP Morgan Chase & Co. | |
| 29.01.21 | Sartorius vz. overweight | JP Morgan Chase & Co. | |
| 27.01.21 | Sartorius vz. overweight | JP Morgan Chase & Co. | |
| 27.01.21 | Sanofi overweight | JP Morgan Chase & Co. | |
| 26.01.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 21.01.21 | Sartorius vz. overweight | JP Morgan Chase & Co. | |
| 21.01.21 | Merck overweight | JP Morgan Chase & Co. | |
| 20.01.21 | Merck overweight | JP Morgan Chase & Co. | |
| 18.01.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 14.01.21 | Sanofi overweight | JP Morgan Chase & Co. | |
| 14.01.21 | Merck overweight | JP Morgan Chase & Co. | |
| 13.01.21 | Merck overweight | JP Morgan Chase & Co. | |
| 04.01.21 | Sartorius vz. overweight | JP Morgan Chase & Co. | |
| 04.01.21 | Novo Nordisk kaufen | JP Morgan Chase & Co. | |